Non cancer causes of death after gallbladder cancer diagnosis: a population-based analysis.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
23 08 2023
23 08 2023
Historique:
received:
04
03
2023
accepted:
05
08
2023
medline:
25
8
2023
pubmed:
24
8
2023
entrez:
23
8
2023
Statut:
epublish
Résumé
Mortality from non cancer causes in patients with gallbladder cancer (GBC) still unclear. This study evaluated the causes and risk factors of non cancer death during different follow-up periods after GBC diagnosis. Non cancer causes of death for GBC patients diagnosed between 2000 and 2017 in Surveillance, Epidemiology and End Results database were analyzed and standardized mortality rates (SMR) for each non cancer death were calculated. Predictors for non cancer death were identified through multivariate competing risk analysis. A total 11,927 GBC patients were identified for further analysis, 9393 died during follow up. The largest proportion of non cancer deaths occurred > 3 years after diagnosis (39.4%). Most common non cancer cause were cardiovascular disease (43.3%), followed by other cause of death (34.4%) and infectious diseases (8.6%). Compared with US general population, GBC patients has higher risk of death from disease of heart (SMR, 1.58; 95%CI, 1.41-1.75), septicemia (SMR,3.21; 95%CI, 2.27-4.40), diabetes mellitus (SMR,1.97; 95%CI, 1.43-2.63), alone with other causes. Non cancer causes accounted for a significant proportion of deaths during the follow-up period after GBC diagnosis. The risk of non cancer death is higher in GBC patients than in the general population. Our study provides comprehensive assessment of death from non cancer cause in GBC patients, which has important implications for health management in GBC patients.
Identifiants
pubmed: 37612302
doi: 10.1038/s41598-023-40134-4
pii: 10.1038/s41598-023-40134-4
pmc: PMC10447554
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
13746Informations de copyright
© 2023. Springer Nature Limited.
Références
Low, S. K. et al. Trends in primary gallbladder cancer incidence and incidence-based mortality in the United States, 1973 to 2015. Am. J. Clin. Oncol. 45(7), 306–315 (2022).
pubmed: 35700074
Sturgeon, K. M. et al. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur. Heart J. 40(48), 3889–3897 (2019).
pubmed: 31761945
pmcid: 6925383
Zaorsky, N. G. et al. Suicide among cancer patients. Nat. Commun. 10(1), 207 (2019).
pubmed: 30643135
pmcid: 6331593
Zhu, X. et al. Diabetic mortality risk among cancer patients in the United State SEER population, 1975–2016. Endocrine 70(2), 323–330 (2020).
pubmed: 32643048
Wang, Q., Zeng, Z., Nan, J., Zheng, Y. & Liu, H. Cause of death among patients with thyroid cancer: A population-based study. Front. Oncol. 12, 852347 (2022).
pubmed: 35359353
pmcid: 8964038
Huang, J. et al. Worldwide distribution, associated factors, and trends of gallbladder cancer: A global country-level analysis. Cancer Lett. 521, 238–251 (2021).
pubmed: 34506845
Chen, J. et al. Primary renal lymphoma: A population-based study in the United States, 1980–2013. Sci. Rep. 9(1), 15125 (2019).
pubmed: 31641184
pmcid: 6805900
Afifi, A. M. et al. Causes of death following nonmetastatic colorectal cancer diagnosis in the USA population-based analysis. Oncologist 26(9), 733–739 (2021).
pubmed: 34101294
pmcid: 8417843
Wu, X. Q., Li, J. Y. & Du, W. J. Causes of death following small cell lung cancer diagnosis: A population-based analysis. BMC Pulm. Med. 22(1), 262 (2022).
pubmed: 35787685
pmcid: 9254402
Ruparel, M. et al. Evaluation of cardiovascular risk in a lung cancer screening cohort. Thorax 74(12), 1140–1146 (2019).
pubmed: 31558626
Sun, J. Y. et al. Cardiovascular disease-specific mortality in 270,618 patients with non-small cell lung cancer. Int. J. Cardiol. 330, 186–193 (2021).
pubmed: 33581175
Armenian, S. H. et al. Cardiovascular disease among survivors of adult-onset cancer: A community-based retrospective cohort study. J. Clin. Oncol. 34(10), 1122–1130 (2016).
pubmed: 26834065
pmcid: 7357493
Totzeck, M., Schuler, M., Stuschke, M., Heusch, G. & Rassaf, T. Cardio-oncology-strategies for management of cancer-therapy related cardiovascular disease. Int. J. Cardiol. 280, 163–175 (2019).
pubmed: 30661849
Shen, Q. et al. Injuries before and after diagnosis of cancer: Nationwide register based study. BMJ 354, i4218 (2016).
pubmed: 27582045
Fang, F. et al. Suicide and cardiovascular death after a cancer diagnosis. N. Engl. J. Med. 366(14), 1310–1318 (2012).
pubmed: 22475594
Pinheiro, L. C., Soroka, O., Kern, L. M., Leonard, J. P. & Safford, M. M. Diabetes care management patterns before and after a cancer diagnosis: A SEER-Medicare matched cohort study. Cancer 126(8), 1727–1735 (2020).
pubmed: 31999848
Carver, J. R. et al. American society of clinical oncology clinical evidence review on the ongoing care of adult cancer survivors: Cardiac and pulmonary late effects. J. Clin. Oncol. 25(25), 3991–4008 (2007).
pubmed: 17577017
Armenian, S. H. et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American society of clinical oncology clinical practice guideline. J. Clin. Oncol. 35(8), 893–911 (2017).
pubmed: 27918725
Chanock, S. Evolving risk factors for infectious complications of cancer therapy. Hematol. Oncol. Clin. North Am. 7(4), 771–793 (1993).
pubmed: 8354656
Zembower, T. R. Epidemiology of infections in cancer patients. Cancer Treat. Res. 161, 43–89 (2014).
pubmed: 24706221
pmcid: 7120867
Donnelly, J. P., Blijlevens, N. M. & van der Velden, W. J. Host impairments in patients with neoplastic diseases. Cancer Treat. Res. 161, 1–41 (2014).
pubmed: 24706220
pmcid: 7119925
Yang, P. et al. Immediate risk of non-cancer deaths after a cancer diagnosis. BMC Cancer 21(1), 963 (2021).
pubmed: 34452598
pmcid: 8394256
Goldszmid, R. S., Dzutsev, A. & Trinchieri, G. Host immune response to infection and cancer: Unexpected commonalities. Cell Host Microbe. 15(3), 295–305 (2014).
pubmed: 24629336
pmcid: 3996827
Liyanage, U. K. et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J. Immunol. 169(5), 2756–2761 (2002).
pubmed: 12193750
Chen, J. et al. Cause of death among patients with colorectal cancer: A population-based study in the United States. Aging 12(22), 22927–22948 (2020).
pubmed: 33289707
pmcid: 7746372
Hiong, A. et al. Sepsis following cancer surgery: the need for early recognition and standardised clinical care. Expert Rev. Anti Infect. Ther. 14(4), 425–433 (2016).
pubmed: 26882129
Liu, Z., Mahale, P. & Engels, E. A. Sepsis and risk of cancer among elderly adults in the United States. Clin. Infect. Dis. 68(5), 717–724 (2019).
pubmed: 29982318
Kochanek, M. et al. Management of sepsis in neutropenic cancer patients: 2018 guidelines from the infectious diseases working party (AGIHO) and intensive care working party (iCHOP) of the German society of hematology and medical oncology (DGHO). Ann. Hematol. 98(5), 1051–1069 (2019).
pubmed: 30796468
pmcid: 6469653
Schreiber, R. D., Old, L. J. & Smyth, M. J. Cancer immunoediting: Integrating immunity’s roles in cancer suppression and promotion. Science 331(6024), 1565–1570 (2011).
pubmed: 21436444
Yu, D. D. et al. Cause of death during renal cell carcinoma survivorship: A contemporary population-based analysis. Front. Oncol. 12, 864132 (2022).
pubmed: 35719910
pmcid: 9201523
de Montmollin, E. et al. Outcomes in critically ill cancer patients with septic shock of pulmonary origin. Shock 39(3), 250–254 (2013).
pubmed: 23364436
Elhadi, M., Khaled, A. & Msherghi, A. Infectious diseases as a cause of death among cancer patients: A trend analysis and population-based study of outcome in the United States based on the surveillance, epidemiology, and end results database. Infect. Agent Cancer 16(1), 72 (2021).
pubmed: 34972537
pmcid: 8719405
Giovannucci, E. et al. Diabetes and cancer: A consensus report. Diabetes Care 33(7), 1674–1685 (2010).
pubmed: 20587728
pmcid: 2890380
Accordino, M. K. et al. Incidence and predictors of diabetes mellitus after a diagnosis of early-stage breast cancer in the elderly using real-world Data. Breast Cancer Res. Treat. 183(1), 201–211 (2020).
pubmed: 32591988
pmcid: 8403515
Wang, L., Tang, K., Li, X. & Lu, W. Anti-PD-1-based immunotherapy plus lenvatinib to treat advanced gallbladder cancer in the elderly: A case series and review of current literature. J. Cancer Res. Clin. Oncol. 149(3), 941–950 (2022).
pubmed: 35759010
Chen, R. C., Royce, T. J., Extermann, M. & Reeve, B. B. Impact of age and comorbidity on treatment and outcomes in elderly cancer patients. Semin. Radiat. Oncol. 22(4), 265–271 (2012).
pubmed: 22985808
Kim, M. G., Kim, H. S., Kim, B. S. & Kwon, S. J. The impact of old age on surgical outcomes of totally laparoscopic gastrectomy for gastric cancer. Surg. Endosc. 27(11), 3990–3997 (2013).
pubmed: 23877760
Chen, C. et al. Competing risk analysis of cardiovascular death in patients with primary gallbladder cancer. Cancer Med. 12(3), 2179–2186 (2022).
pubmed: 35920057
pmcid: 9939154
Mo, X., Zhou, M., Yan, H., Chen, X. & Wang, Y. Competing risk analysis of cardiovascular/cerebrovascular death in T1/2 kidney cancer: A SEER database analysis. BMC Cancer 21(1), 13 (2021).
pubmed: 33402111
pmcid: 7786899
Patel, R. K., Ford, E., Thumpston, J. & Arya, R. Risk factors for venous thrombosis in the black population. Thromb. Haemost. 90(5), 835–838 (2003).
pubmed: 14597978
Jiang, S. et al. A novel nomogram based on log odds of positive lymph nodes to predict survival for non-metastatic gallbladder adenocarcinoma after surgery. Sci. Rep. 12(1), 16466 (2022).
pubmed: 36183006
pmcid: 9526724
Guo, Y. et al. Causes of death after prostate cancer diagnosis: A population-based study. Oxid. Med. Cell. Longev. 2022, 8145173 (2022).
pubmed: 35502209
pmcid: 9056212
Hoang, G., Nguyen, K. & Le, A. Metabolic intersection of cancer and cardiovascular diseases: Opportunities for cancer therapy. Adv. Exp. Med. Biol. 1311, 249–263 (2021).
pubmed: 34014548
pmcid: 9703259
Osborne, N. H., Wakefield, T. W. & Henke, P. K. Venous thromboembolism in cancer patients undergoing major surgery. Ann. Surg. Oncol. 15(12), 3567–3578 (2008).
pubmed: 18841419
Agnelli, G. et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: The @RISTOS project. Ann. Surg. 243(1), 89–95 (2006).
pubmed: 16371741
pmcid: 1449979
Guan, T. et al. Cardiovascular death risk in primary central nervous system lymphoma patients treated with chemotherapy: A registry-based cohort study. Front. Oncol. 11, 641955 (2021).
pubmed: 34046345
pmcid: 8147725
Xia, Y., Lin, M., Huang, J. & Fan, L. Cardiovascular disease related death among patients with esophagus cancer: A population-based competing risk analysis. Front. Oncol. 12, 976711 (2022).
pubmed: 36185282
pmcid: 9522624
Haugnes, H. S. et al. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: A 20-year follow-up study. J. Clin. Oncol. 28(30), 4649–4657 (2010).
pubmed: 20855830